39-Week Elective Induction

Premises of Elective Induction 
The medical community often assumes that waiting for labour has no benefits and that inducing labour has no harms. Henci argues that spontaneous labour is physiologically beneficial, preparing both mother and baby for birth and breastfeeding.

ARRIVE Trial Limitations 
The ARRIVE trial’s results are not necessarily generalisable to typical hospital settings, as the trial’s management and conditions were not representative of standard care.

Cesarean Rates 
When other studies are taken into account, routine 39-week induction does not reduce caesarean rates as the ARRIVE trial suggested; in fact, rates often increase.

Medical vs. Physiologic Approaches 
The medical approach views pregnancy and birth as inherently risky, while physiologic care starts from the premise that pregnancy and childbirth are healthy, normal experiences.

Induction for Non-Medical Reasons 
Many inductions are performed for convenience or precautionary reasons, not medical necessity, which can lead to a higher rate of interventions.

Impact of IV Oxytocin 
IV oxytocin, commonly used in inductions, disrupts natural oxytocin release, which is crucial for pain management, stress reduction, and bonding.

Fetal Surveillance Tests 
Henci points out that routine fetal surveillance tests often lead to false positives, increasing the rate of inductions and caesareans without necessarily improving neonatal outcomes.

Physiologic Care Reduces Caesareans 
Practices like doula support, midwife-led care, intermittent auscultation, and mobility during labour and one-to-one continuous labour support can have a significant positive impact on caesarean rates. 

Better Neonatal Outcomes 
Physiologic care results in fewer babies admitted to special care nurseries, compared to elective induction at 39 weeks.

Variation in Induction Policies 
Induction policies and intervention rates vary widely between hospitals and providers, depending on the internal ‘culture’. 

Conclusion
Henci concludes that the ARRIVE trial inadvertently that the best outcomes will be achieved in a model of care that supports the physiologic process and reserves induction for circumstances when the benefits of inducing outweigh the risks.